OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX
OTC Markets Group (OTCQX: OTCM) announced that Enzo Biochem (OTCQX: ENZB), a life sciences company, has qualified to trade on the OTCQX® Best Market after transitioning from the New York Stock Exchange. Trading commenced under the symbol 'ENZB' on April 21, 2025.
The OTCQX Market provides companies with cost-effective access to U.S. capital markets through streamlined requirements while maintaining transparency for investors. Companies must meet high financial standards, follow best practice corporate governance, and demonstrate securities law compliance to qualify.
CEO Kara Cannon expressed satisfaction with the transition, highlighting OTCQX's platform for investor engagement while maintaining their focus on life science products and services.
OTC Markets Group (OTCQX: OTCM) ha annunciato che Enzo Biochem (OTCQX: ENZB), un'azienda nel settore delle scienze della vita, ha ottenuto l'idoneità a negoziare sul mercato OTCQX® Best Market dopo il passaggio dalla Borsa di New York. Le contrattazioni sono iniziate con il simbolo 'ENZB' il 21 aprile 2025.
Il mercato OTCQX offre alle aziende un accesso economico ai mercati dei capitali statunitensi attraverso requisiti semplificati, garantendo al contempo trasparenza agli investitori. Le aziende devono soddisfare elevati standard finanziari, adottare le migliori pratiche di governance aziendale e dimostrare la conformità alle normative sui titoli per qualificarsi.
La CEO Kara Cannon ha espresso soddisfazione per la transizione, sottolineando come la piattaforma OTCQX favorisca l'interazione con gli investitori senza perdere di vista il focus sui prodotti e servizi nel campo delle scienze della vita.
OTC Markets Group (OTCQX: OTCM) anunció que Enzo Biochem (OTCQX: ENZB), una empresa de ciencias de la vida, ha calificado para cotizar en el mercado OTCQX® Best Market tras su transición desde la Bolsa de Nueva York. Las operaciones comenzaron bajo el símbolo 'ENZB' el 21 de abril de 2025.
El mercado OTCQX ofrece a las empresas un acceso rentable a los mercados de capitales de EE.UU. mediante requisitos simplificados, manteniendo la transparencia para los inversores. Las empresas deben cumplir con altos estándares financieros, seguir las mejores prácticas de gobernanza corporativa y demostrar cumplimiento de la legislación de valores para calificar.
La CEO Kara Cannon expresó su satisfacción con la transición, destacando la plataforma OTCQX para el compromiso con los inversores mientras mantienen su enfoque en productos y servicios de ciencias de la vida.
OTC Markets Group (OTCQX: OTCM)는 생명과학 기업인 Enzo Biochem (OTCQX: ENZB)가 뉴욕증권거래소에서 OTCQX® Best Market으로 이전하여 거래 자격을 획득했다고 발표했습니다. 거래는 2025년 4월 21일부터 'ENZB' 심볼로 시작되었습니다.
OTCQX 시장은 간소화된 요건을 통해 미국 자본 시장에 비용 효율적으로 접근할 수 있도록 하며, 투자자에게는 투명성을 제공합니다. 기업은 높은 재무 기준을 충족하고, 모범적인 기업 지배구조를 따르며, 증권법 준수를 입증해야 자격을 얻을 수 있습니다.
CEO 카라 캐넌은 전환에 만족감을 표하며, OTCQX 플랫폼이 투자자와의 소통을 촉진하는 동시에 생명과학 제품과 서비스에 집중할 수 있게 한다고 강조했습니다.
OTC Markets Group (OTCQX : OTCM) a annoncé que Enzo Biochem (OTCQX : ENZB), une entreprise des sciences de la vie, a obtenu la qualification pour être cotée sur le marché OTCQX® Best Market après sa transition depuis la Bourse de New York. Les négociations ont commencé sous le symbole 'ENZB' le 21 avril 2025.
Le marché OTCQX offre aux entreprises un accès rentable aux marchés financiers américains grâce à des exigences simplifiées tout en garantissant la transparence pour les investisseurs. Les entreprises doivent respecter des normes financières élevées, adopter les meilleures pratiques de gouvernance d’entreprise et démontrer leur conformité aux lois sur les valeurs mobilières pour être éligibles.
La PDG Kara Cannon a exprimé sa satisfaction quant à cette transition, soulignant que la plateforme OTCQX favorise l’engagement des investisseurs tout en maintenant leur concentration sur les produits et services des sciences de la vie.
OTC Markets Group (OTCQX: OTCM) gab bekannt, dass Enzo Biochem (OTCQX: ENZB), ein Unternehmen aus den Lebenswissenschaften, sich qualifiziert hat, am OTCQX® Best Market zu handeln, nachdem es von der New Yorker Börse gewechselt ist. Der Handel begann am 21. April 2025 unter dem Symbol 'ENZB'.
Der OTCQX-Markt bietet Unternehmen kosteneffizienten Zugang zu den US-Kapitalmärkten durch vereinfachte Anforderungen und gewährleistet dabei Transparenz für Investoren. Unternehmen müssen hohe finanzielle Standards erfüllen, bewährte Corporate-Governance-Praktiken einhalten und die Einhaltung der Wertpapiergesetze nachweisen, um sich zu qualifizieren.
CEO Kara Cannon zeigte sich zufrieden mit dem Übergang und hob hervor, dass die OTCQX-Plattform die Investoreneinbindung fördert, während der Fokus auf Produkten und Dienstleistungen im Bereich der Lebenswissenschaften erhalten bleibt.
- Cost reduction through streamlined market requirements
- Maintained access to U.S. capital markets with transparent trading
- Downgrade from NYSE listing to OTCQX market may indicate reduced market presence
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Enzo Biochem, Inc. (OTCQX: ENZB), life sciences company, has qualified to trade on the OTCQX® Best Market. Enzo Biochem, Inc. previously traded on the New York Stock Exchange.
Enzo Biochem, Inc. begins trading today on OTCQX under the symbol “ENZB.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for their investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.
“Enzo Biochem, Inc. is pleased to begin trading on the OTCQX, which provides an excellent platform for investors to engage with the company as we continue to provide exceptional life science products and services,” said Kara Cannon, CEO of Enzo Biochem, Inc.
About Enzo Biochem, Inc.
Enzo Biochem, Inc. has operated as a life sciences company for over 45 years. The primary business of Enzo today is conducted through its Life Sciences division, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through our global distribution network and licensing. Enzo Life Sciences is operated through the Company’s wholly-owned subsidiary Enzo Life Sciences, Inc. and its wholly-owned foreign subsidiaries.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATSTM are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
FAQ
Why did Enzo Biochem (ENZB) move from NYSE to OTCQX in April 2025?
What are the requirements for trading on OTCQX Best Market?
When did Enzo Biochem (ENZB) begin trading on OTCQX?
How many securities does OTC Markets Group (OTCM) operate markets for?
